Home » Who we are
We understand the significance of what you bring to patients.
We understand you
Lupin Manufacturing Solutions (LMS) is a wholly owned subsidiary of Lupin, a trusted name in the pharmaceutical industry with a legacy of fulfilling unmet patient needs for over five decades. We specialize in manufacturing and supplying high-quality, cost-effective Active Pharmaceutical Ingredients (APIs) and are the “Partner of Choice” in the Contract Development and Manufacturing Operations (CDMO) space for Drug substance.
A Legacy of Quality
We have earned the trust of clients globally who count on us for a reliable supply of high-quality APIs. The hub of all the action is our research facility in Pune and our two manufacturing facilities in Dabhasa and Vizag in India. From here, the API and CDMO requirements of clients are fulfilled. Quality is a part of our DNA. We follow cGMP guidelines to ensure the highest standards of safety and compliance. Both our manufacturing sites comply with all regulatory standards and are approved by the U.S. FDA, EDQM, PMDA, TGA, and Health Canada, among others.
From Test Tube to Market
Our vertically integrated and sustainability-focused operations ensure seamless delivery of services and products from concept to commercialization across global markets. Our R&D prowess, coupled with expertise in scale -up and manufacturing under Good Manufacturing Practices and our ability to meet regulatory requirements even in geographies with the most stringent compliance requirements, enable us to take your molecule from test tube to market within the optimal span of time. Lupin Manufacturing Solutions will be your partner on your journey as you navigate the most stringent regulatory requirements, from development to commercialization.
Commitment to Excellence
Our focus on continuous improvement across all aspects, including people, processes, products and services, is at the center of our commitment to excellence. This approach enables us to deliver delight to our partners in terms of both the quality and cost-effectiveness of our API products and CDMO services.